Friday, June 10, 2022

< + > Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

No comments:

Post a Comment

< + > Merry Christmas and Happy Holidays

The holidays are a time of thanks and that’s definitely true for us as many of the Healthcare IT Today team celebrate Christmas today.  My t...